This area of the web site contains all information which is required to be disclosed in accordance with Rule 26 of the AIM Rules.


Description of the business

Names of the directors, biographical details and responsibilities

Corporate governance

Country of incorporation / operation

Shareholder Information

  • UK City Code on Takeovers and Mergers
  • Other exchanges and trading platforms
  • Number of AIM securities in issue
  • Significant shareholdings
  • Director shareholdings
  • Shares not in public hands
  • Restrictions in transfer of AIM Securities

Financial information

Company announcements

Documents and presentations

  • Admission Document
  • Articles of Association
  • Company presentation


Investor-related news

Verici Dx featured on Edison Open House

Sara Barrington, CEO of Verici Dx, interviews with Edison Open House about goals for 2021 and updates on clinical trials.
Keep Reading

Sara Barrington interviews with Vox Markets

Sara Barrington, CEO of Verici Dx, shares an update with VOX Markets on major developments and key milestones ahead.
Keep Reading